SANTEX S.P.A. – Trademark Portfolio

Entity Type: 99

SANTEX S.P.A. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include SANTEX and ABSORBEO. The owner is based in MILANO (MI).

VIA SAN GIOVANNI SUL MURO, 1

MILANO (MI) 20121 , IT

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SANTEX
SANTEX
Registered 2024
ABSORBEO
ABSORBEO
Registered 2023
EGOSAN
EGOSAN
Pending 2018

Trademark Classifications

SANTEX S.P.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SANTEX S.P.A. have?

SANTEX S.P.A. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending.

What trademark classes does SANTEX S.P.A. file in?

SANTEX S.P.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SANTEX S.P.A.'s most well-known trademarks?

SANTEX S.P.A.'s registered trademark portfolio includes well-known marks such as SANTEX and ABSORBEO. These are among 2 currently registered trademarks in the portfolio.

What is SANTEX S.P.A.'s trademark registration success rate?

SANTEX S.P.A. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.